PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B-cell lymphoma

Clin Transl Med. 2022 Apr;12(4):e808. doi: 10.1002/ctm2.808.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Mutation / genetics
  • Phenotype
  • Proto-Oncogene Proteins c-pim-1 / genetics

Substances

  • PIM1 protein, human
  • Proto-Oncogene Proteins c-pim-1